Feedback / Questions
CST-3056 - CuraSen Therap
https://www.businesswire.com/news/home/20250220404883/en/CuraSen-Therapeutics-Announces-First-Subject-Treated-with-CuraAX-CST-3056-in-a-Phase-1-Clinical-Trial
Feb 20, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next